Determinants of long-term outcomes in patients with COVID-19 supported with ECMO - Authors' reply

Affiliations

¹ Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands; Cardiovascular Research Institute Maastricht, Maastricht, Netherlands. Electronic address: roberto.lorusso@mumc.nl.
² Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands; Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.

Comment

Roberto Lorusso et al. Lancet Respir Med. 2023 May.

. 2023 May;11(5):e42.

doi: 10.1016/S2213-2600(23)00134-0. Epub 2023 Apr 5.

¹ Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands; Cardiovascular Research Institute Maastricht, Maastricht, Netherlands. Electronic address: roberto.lorusso@mumc.nl.
² Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands; Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.

No abstract available

Conflict of interest statement

Author declarations remain the same as in the original Article.

In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study.
Lorusso R, De Piero ME, Mariani S, Di Mauro M, Folliguet T, Taccone FS, Camporota L, Swol J, Wiedemann D, Belliato M, Broman LM, Vuylsteke A, Kassif Y, Scandroglio AM, Fanelli V, Gaudard P, Ledot S, Barker J, Boeken U, Maier S, Kersten A, Meyns B, Pozzi M, Pedersen FM, Schellongowski P, Kirali K, Barrett N, Riera J, Mueller T, Belohlavek J; EuroECMO-COVID Study Group. Lorusso R, et al. Lancet Respir Med. 2023 Feb;11(2):151-162. doi: 10.1016/S2213-2600(22)00403-9. Epub 2022 Nov 16. Lancet Respir Med. 2023. PMID: 36402148 Free PMC article.
Determinants of long-term outcomes in patients with COVID-19 supported with ECMO.
Guervilly C, Giani M, Nesseler N, Schmidt M, Hraiech S. Guervilly C, et al. Lancet Respir Med. 2023 May;11(5):e41. doi: 10.1016/S2213-2600(23)00010-3. Epub 2023 Apr 5. Lancet Respir Med. 2023. PMID: 37030309 Free PMC article. No abstract available.

1. Lorusso R, De Piero ME, Mariani S, et al. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study. Lancet Respir Med. 2023;11:151–162. - PMC - PubMed
1. Shekar K, Badulak J, Peek G, et al. Extracorporeal Life Support Organization COVID-19 Interim Guidelines. A consensus document from an international group of interdisciplinary extracorporeal membrane oxygenator providers. ASAIO J. 2020;66:707–721. - PMC - PubMed
1. Zaaqoq AM, Barnett AG, Griffee MJ, et al. Beneficial effect of prone positioning during venovenous extracorporeal membrane oxygenation for coronavirus disease 2019. Crit Care Med. 2022;50:275–285. - PMC - PubMed
1. Giani M, Rezoagli E, Guervilly C, et al. Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a pooled individual patient data analysis. Crit Care. 2022;26:8. - PMC - PubMed
1. Poon WH, Ramanathan K, Ling RR, et al. Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care. 2021;25:292. - PMC - PubMed